These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 33237537)
21. Phenotyping of Myeloid-Derived Suppressor Cells in Nonhuman Primates. Lin A; Loré K Methods Mol Biol; 2021; 2236():9-17. PubMed ID: 33237536 [TBL] [Abstract][Full Text] [Related]
22. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
23. [Variation of subsets of myeloid derived suppressor cells and their ratio in septic mice]. Wang H; Zhao Q; Huang Z; Zhao M; Xu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):147-52. PubMed ID: 26911947 [TBL] [Abstract][Full Text] [Related]
24. In Vitro Generation of Murine Myeloid-Derived Suppressor Cells, Analysis of Markers, Developmental Commitment, and Function. Eckert I; Ribechini E; Lutz MB Methods Mol Biol; 2021; 2236():99-114. PubMed ID: 33237544 [TBL] [Abstract][Full Text] [Related]
26. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs). Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562 [TBL] [Abstract][Full Text] [Related]
27. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. Ostrand-Rosenberg S; Fenselau C J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384 [TBL] [Abstract][Full Text] [Related]
28. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment. Qu P; Wang LZ; Lin PC Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice. Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578 [TBL] [Abstract][Full Text] [Related]
30. Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice. Lu YT; Li J; Qi X; Pei YX; Shi WG; Lin HS Chin J Integr Med; 2017 Jun; 23(6):453-460. PubMed ID: 27796822 [TBL] [Abstract][Full Text] [Related]
31. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative. Karin N Front Immunol; 2020; 11():557586. PubMed ID: 33193327 [TBL] [Abstract][Full Text] [Related]
32. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Dysthe M; Parihar R Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608 [TBL] [Abstract][Full Text] [Related]
33. Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib. Giallongo C; Parrinello NL; La Cava P; Camiolo G; Romano A; Scalia M; Stagno F; Palumbo GA; Avola R; Li Volti G; Tibullo D; Di Raimondo F J Cell Mol Med; 2018 Feb; 22(2):1070-1080. PubMed ID: 29218828 [TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice]. Li B; Chen H; Shi M; Huang N; Kong G; Li Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):802-808. PubMed ID: 32967764 [TBL] [Abstract][Full Text] [Related]
35. Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation. Ochando J; Conde P; Utrero-Rico A; Paz-Artal E Front Immunol; 2019; 10():374. PubMed ID: 30894860 [TBL] [Abstract][Full Text] [Related]
37. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors. Hellsten R; Lilljebjörn L; Johansson M; Leandersson K; Bjartell A Prostate; 2019 Oct; 79(14):1611-1621. PubMed ID: 31348843 [TBL] [Abstract][Full Text] [Related]